Abstract:The benzothiazinone (BTZ) scaffold compound PBTZ169 kills Mycobacterium tuberculosis by inhibiting the essential flavoenzyme DprE1, consequently blocking the synthesis of the cell wall component arabinans. While extraordinarily potent against M. tuberculosis with a minimum inhibitory concentration (MIC) less than 0.2 ng/mL, its low aqueous solubility and bioavailability issues need to be addressed. Here, we designed and synthesized a series of 6-methanesulfonyl substituted BTZ analogues; further exploration introduced five-member aromatic heterocycles as linkers to attach an aryl group as the side chain. Our work led to the discovery of a number of BTZ derived compounds with potent antitubercular activity. The optimized compounds 6 and 38 exhibited MIC 47 and 30 nM, respectively. Compared to PBTZ169, both compounds displayed increased aqueous solubility and higher stability in human liver microsomes. This study suggested that an alternative side-chain modification strategy could be implemented to improve the druglike properties of the BTZ-based compounds.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c01049.Synthetic procedures and characterization for intermediates 52–81; viability of HepG2 cell after 48 h treatment with compounds 6 and 38; 1H and 13C NMR spectra for compounds 1–47; and HPLC trace for compounds 1–47 (PDF)Molecular formula strings of all compounds 1–47 (CSV)This article has not yet been cited by other publications.

Identification of Benzothiazinones Containing an Oxime Functional Moiety As New Anti-Tuberculosis Agents.

Identification of a New Series of Benzothiazinone Derivatives with Excellent Antitubercular Activity and Improved Pharmacokinetic Profiles

Design, synthesis and antitubercular evaluation of benzothiazinones containing an oximido or amino nitrogen heterocycle moiety

Identification of Better Pharmacokinetic Benzothiazinone Derivatives As New Antitubercular Agents.

Identification of Benzothiazones Containing a Hexahydropyrrolo[3,4-C]pyrrol Moiety As Antitubercular Agents Against MDR-MTB

Benzothiozinone derivatives with anti-tubercular Activity−Further side chain investigation

Synthesis and Structure–activity Relationships Evaluation of Benzothiazinone Derivatives As Potential Anti-Tubercular Agents

Identification of N-Benzyl 3,5-Dinitrobenzamides Derived from PBTZ169 As Antitubercular Agents.

Design, Synthesis and Antitubercular Evaluation of Benzothiazinones Containing a Piperidine Moiety

Design, synthesis and antimycobacterial activity of novel benzothiazinones with improved water solubility

Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity

Design, synthesis and biological activity of N-(amino)piperazine-containing benzothiazinones against Mycobacterium tuberculosis

Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents

Discovery of New Chemical Entities As Potential Leads Against Mycobacterium Tuberculosis.

Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents

Identification of novel benzothiopyranones with ester and amide motifs derived from active metabolite as promising leads against Mycobacterium tuberculosis

Towards a new combination therapy for tuberculosis with next generation benzothiazinones

Synthesis and Antitubercular Evaluation of Reduced Lipophilic Imidazo[1,2-A]pyridine-3-carboxamide Derivatives

Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides As Novel Antitubercular Agents.

Design, synthesis and antimycobacterial activity of novel nitrobenzamide derivatives

Synthesis and Evaluation of Anti-Tubercular and Antibacterial Activities of New 4-(2,6-dichlorobenzyloxy)phenyl Thiazole, Oxazole and Imidazole Derivatives. Part 2